<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04509687</url>
  </required_header>
  <id_info>
    <org_study_id>ROSE</org_study_id>
    <nct_id>NCT04509687</nct_id>
  </id_info>
  <brief_title>Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions</brief_title>
  <acronym>EUS-FNA</acronym>
  <official_title>Feasibility Study of Training Endoscopists to Perform On-site Rapid Cytological Evaluation for Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changhai Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In China, there is a serious shortage of pathologists who can perform on-site cytological&#xD;
      diagnosis. As a result, there are few centers that can conduct ROSE in China, which limits&#xD;
      the diagnostic accuracy of EUS-FNA to a certain extent. Previous research reports on whether&#xD;
      endoscopists could be trained for ROSE were controversial, which may be related to the lack&#xD;
      of standardization of the training of endoscopists. There is no training program for training&#xD;
      endoscopists to systematically process pathological specimens, operate microscopes, read the&#xD;
      adequacy of cytological specimens, and evaluate the atypia of cytological specimens in China.&#xD;
      Therefore, our center intends to carry out a training for endoscopists to compare the&#xD;
      improvement of endoscopists' ROSE operating ability before and after the training, and to&#xD;
      evaluate the practice of each endoscopist to perform on-site rapid cytology specimens of&#xD;
      solid pancreatic lesions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of endoscopists for interpretation of cytologic specimen adequacy and primary diagnosis of malignancy</measure>
    <time_frame>10 months</time_frame>
    <description>The interpretation results of endoscopists will be compared with that of cytopathologist.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The results of standard specimens-processing, microscope-operating training on endoscopists</measure>
    <time_frame>3 months</time_frame>
    <description>Comparison of the score that endoscopists are graded before and after the standard training</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pancreatic Cancer</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      pancreatic sample acquired from EUS-FNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We plan to involve 60 patients with solid pancreatic lesion, with trained endoscopists&#xD;
        performing ROSE in the procedure of EUS-FNA&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. age ≥18 years&#xD;
&#xD;
          2. diagnosis or suspected of solid pancreatic mass based on previous imaging examination;&#xD;
&#xD;
          3. EUS-FNA is achievable.&#xD;
&#xD;
          4. signed informed consent letter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. pregnant female&#xD;
&#xD;
          2. pancreatic cystic lesions&#xD;
&#xD;
          3. anticoagulant/antiplatelet therapy cannot be suspended&#xD;
&#xD;
          4. unable or refuse to provide informed consent&#xD;
&#xD;
          5. coagulopathy (platelet count &lt;50 ×103/uL, international normalized ration &gt;1.5）&#xD;
&#xD;
          6. severe cardiopulmonary dysfunction that cannot tolerate intravenous anesthesia&#xD;
&#xD;
          7. with history of mental disease&#xD;
&#xD;
          8. other medical conditions that are not suitable for EUS-FNA&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shi-yu Li, M.D.</last_name>
    <phone>+8615521243639</phone>
    <email>lizfish@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kai-xuan Wang, Dr./M.D.</last_name>
    <phone>+8613585673477</phone>
    <email>wangkaixuan224007@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Changhai Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>210000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhen-dong Jin, Ph.D</last_name>
      <phone>13901618837</phone>
      <email>zhendjin@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>August 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 12, 2020</study_first_posted>
  <last_update_submitted>August 10, 2020</last_update_submitted>
  <last_update_submitted_qc>August 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changhai Hospital</investigator_affiliation>
    <investigator_full_name>Zhaoshen Li</investigator_full_name>
    <investigator_title>chief of the gastroenterology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

